Bioactivity validation of Phyllanthus amarus using cell lines as model systems by Ngbolua, Koto-te-Nyiwa et al.





Corresponding author, E-mail: jpngbolua@unikin.ac.cd; 1Molecular & Cell Biology and Biochemistry Unit, Department of Biology, 
2Natural products and Medicinal chemistry Laboratory, Department of Chemistry, 3Scientific Committee for Research, Conservation 
and the Development of Biodiversity; Faculty of Science, University of Kinshasa, P.O. Box 190 Kinshasa XI, Democratic Republic 
of the Congo. Copyright: © 2015 The Authors. This is an open-access article distributed under the terms of the Creative 
Commons Attribution License. 
Koto-te-Nyiwa Ngbolua1,2,3,*, Virima Mudogo2, Pius T. Mpiana2, Masengo C. Ashande3, 
Clovis S. Ndege2,  Damien S.T. Tshibangu2, Dorothee D. Tshilanda2 
Discovery Phytomedicine 2015; 2 (4): 23-28. doi: 10.15562/phytomedicine.2015.29 
www.phytomedicine.ejournals.ca 








Medicinal plants constitute an important component of flora and are widely distributed in the Democratic 
Republic of the Congo (DRC). The aim of the present study was to validate scientifically both the anti-malarial 
effectiveness and safety of Phyllanthus amarus a medicinal plant traditionally used to treat malaria in DRC 
using standardized model systems. Ethanolic crude extracts of P. amarus were evaluated for the inhibitory 
effects on two malaria parasites strains (P. falciparum FcM29 & P. yoelii subsp nigeriensis) while cytotoxicity of 
the plant extract was carried out against leukaemia P-388 cell lines. Results indicate that, P. amarus displayed 
good activity both in vitro and in vivo. While the crude extract displayed toxic effect towards P-388 cells. So, 
the wide use of this medicinal plant in Congolese Folk Medicine as anti-malarial herbal could constitutes a 
great risk of population poisoning. From this study, it can be predicted that P. amarus possess secondary 
metabolites with considerable cytotoxic potency and could lead to the discovery of useful anti-cancer drugs of 
plant origin. 
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Introduction 
Phyllanthus amarus Schum. & Thonn. is a 
small herb belonging to the Phyllanthaceae family. 
This plant is a branching annual glabrous herb 
which is 30-60 cm high and has slender, leaf-
bearing branchlets, distichous leaves which are 
subsessile, elliptic-oblong, obtuse, rounded base. 
Flowers are yellowish, whitish or greenish, 
auxillary, males’ flowers in groups of 1-3 whereas 
females are solitary. Fruits are depressed-globose 
like smooth capsules present underneath the 
branches and seeds are trigonous, pale brown with 
longitudinal parallel ribs on the back.1 The plant 
species is well known for its medicinal properties 
and widely used worldwide. In Indian Ayurvedic 
system of medicine as well as in African 
Traditional Medicine, the plant is used in various 
ailments such as stomach, genitourinary system, 
liver, and kidney and spleen problems. It is bitter, 
astringent, stomachic, diuretic, febrifuge and 
antiseptic. The whole plant is used in gonorrhea, 
menorrhagia and other genital affections. It is 
useful in gastropathy, diarrhoea, dysentery, 
ophthalmopathy, scabies, ulcers, wounds and 
intermittent fevers.2 In Democratic Republic of 
the Congo (DRC), the plant is used in the 
treatment of malaria3 which is an infectious 
disease caused by a protozoan of the phylum: 
Apicomplexa, class: Sporozoa, subclass: Coccidia, 
suborder: Haemosporina, family: Plasmodidae, 
genus Plasmodium.4  
Each year about 300-400 million cases of 
malaria infections are recorded. In Africa, official 
estimations of annual mortality indicate that 1-3 
million cases of deaths are due to malaria. Most of 
the victims are children under the age of 5 years.5, 6 
With fast spreading multidrug resistance to 
commonly used quinoline-based antimalarial drug 
like chloroquine by human malaria parasite 
Plasmodium falciparum, the efficient therapeutic 
approach is seriously weaken. It is therefore 
necessary to screen medicinal plants traditionally 
used to treat malaria by local communities for 
their therapeutic properties and cytotoxicity.3, 7-11   
DRC is a big country located in the heart 
of Africa hosting a wide variety of plant species of 
ethno-medical relevance.11, 12-22 These plant species 
represent an enormous reservoir of secondary 
metabolites with biopharmaceutical potential for 
modern industries.  
The present work was undertaken with 
the aim of evaluating the in vitro and in vivo 
antimalarial and cytotoxic activities of Phyllanthus 
amarus from DRC. Such information would be 
useful in evaluating the effectiveness (efficacy and 
safety) of such herbal medicine by providing 
baseline information for large scale exploitation.  
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Materials and Methods 
Plant identification and preparation of extracts 
Plant was identified by Professor Félicien 
Lukoki Luyeye. Voucher specimen is deposit at 
Herbarium of the Biology department, Faculty of 
Science (Université de Kinshasa, DRC). This plant 
species were selected based on empirical evidence 
of it clinical use by traditional healers as reported 
in the literature.23 The dried and powdered leaves 
(50 g) were repeatedly extracted by cold 
percolation with ethanol 90° EtOH (200 mL x 1) 
for 72 hrs. Chlorophyll was removed using 
activated carbon. Filtrates were mixed and the 
solvent was evaporated under reduced pressure 
using a rotary evaporator. 
 
Antimalarial bioassays 
Parasites strain and in vitro culture conditions  
The asexual erythrocytes’ stages of 
Plasmodium falciparum FcM29-Cameroon, a 
highly chloroquine-resistant strain were grown 
continuously in stock cultures by a modification of 
the method of Trager and Jensen using glucose-
enriched RPMI 1640 medium, supplemented with 
10% human serum at 37°C as previously 
described.3,7-9,11 
 
Test extract preparation 
Methanol (MeOH, 200 μL) was added to 
1 gm sample of extract and further diluted as 
required in water. The MeOH concentration for 
tested dilutions was not greater than 1%. Initial 
concentration of the plant extracts was 50 μg/mL 
diluted with five-fold dilutions to make five 
concentrations, the lowest being 0.08 μg/mL. 
Each test included an untreated control with the 
solvent and a positive control: chloroquine 
sulphate (Sigma, France) and ethanolic crude 
extract of Cinchona stem bark. 
 
Isotopic micro test 
In vitro antiplasmodial activity of the plant 
extracts was evaluated by an isotopic micro test 
which determines the inhibition of radio labeled 
hypoxanthine up take by malaria parasite as an 
indicator of grown. Two hundred micro litres (200 
μL) of total culture medium with the diluted 
extract (20 μL) and the suspension (180 μL) of 
Plasmodium falciparum-infected human red blood 
cells in medium (O+ group, 1% haematocrit) with 
1% asynchronous parasitaemia was placed into the 
wells of 96-well micro titre plates. After 18 h 
incubation of the parasites with the extracts at 
37°C, [3H] hypoxanthine (Amersham, UK) was 
added to each well and the incubation was 
continued for another 24 h at the same conditions. 
The mean values for uptake of 3H-
hypoxanthine (disintegration per minute, dpm) in 
control (untreated) and tested parasitized 
erythrocytes, expressed as the percentage of 
inhibition, were calculated as previously 
reported.7,8 The antimalarial activity of extracts 
was expressed by the inhibitory concentrations 
50% (IC50), representing the concentration of drug 
that induced 50% parasitemia decrease compared 
to control culture. The extract concentration at 
which the parasite growth (ie [3H] hypoxanthine 
uptake) is inhibited by 50% (IC50) was calculated 
by a non-linear regression analysis processed on 
dose–response curves with the help of Mikro Win 
Hidex 2000 software. Liquid scintillation counting 
was operated on CHAMELEONTMV multilabel 
counter plate.7-9,11 
 
Suppressive parasitaemia assay 
The in vivo antimalarial activity of plant 
extracts was determined by the classical 4-day 
suppressive test against Plasmodium yoelii subsp 
nigeriensis strain. Briefly, adult male Swiss albino 
mice weighing 18 to 22 g were inoculated by 
intravenous (iv) route with 107 Plasmodium yoelii 
infected red blood cells. The mice were randomly 
divided in groups of five per batch, and treated 
during four consecutive days with daily doses of 
the extracts, by oral route. Two control groups 
were used in each experiment, one was treated 
with ethanolic crude extract of Cinchona stem 
bark (100 mg/kg, orally), the other group was kept 
untreated. On the 5th day after parasite 
inoculation, blood smears were prepared from all 
mice, fixed with methanol, stained with Diff 
Quick® RAL dyes, then microscopically examined 
(800 × magnifications). 
 
Counting 
Parasitaemia was determined in coded 
blood smears by counting 2000–6000 erythrocytes 
in the case of low parasitaemia (≤1%); or up to 
1000 erythrocytes in the case of higher 
parasitaemia. The parasitaemia for each mouse 
was obtained, and the percentage inhibition of 
parasitaemia for each dose of extracts was 
calculated as previously reported.3, 7, 8, 11 
The extracts were considered active if 
parasitaemia was reduced by 3300±2, 63% or 
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more. Extract was tested at daily dose of 500 
mg/kg body weight. 
 
Cytotoxicity assay 
Cytotoxicity was determined against 
mouse leukaemia cell line P388. Cells were 
cultured in RPMI 1640 (Gibco-BRL) 
supplemented with 10% (v/v) foetal calf serum, 
100 U/mL penicillin and 100 g/mL streptomycin 
and 50 mM 2-mercaptoethanol at 37 °C with 5% 
CO2. Briefly, 5 × 103 cells (based on cell growth 
characteristics) in 180 μl medium were seeded to 
each of 96 wells in a microtiter plate (3 
wells/dose). Various concentrations of plant 
extract diluted in 20 μL cell medium were added. 
The cells were incubated at 37°C, 5% CO2 and 
100% humidity. Cell viability was assessed with 
the neutral red assay, which is based on the uptake 
and intracellular accumulation of the supra vital 
dye.  
Following 72 h incubation with test 
solution, the cells were incubated with neutral red 
dye to assess cytotoxicity. Viable cells actively 
transport this dye across their cell membrane, 
therefore upon subsequent lysis, absorbance can 
be used as a measure of cell viability. A foil-
wrapped 20 mg/mL methanol stock suspension 
of NR was stored at room temperature. The stock 
was diluted to a working concentration of 100 
μg/mL NR in exposure medium and incubated 
overnight at 37°C. Prior to use, this solution was 
centrifuged to remove fine dye crystals. After a 72 
h exposure with the test extract, the medium was 
removed, 100 μL of NR-containing medium 
(freshly prepared neutral red solution pre warmed 
to 37°C) was added per well, and incubation was 
continued for 1 h at 37°C.  
The cells were washed three times with 
PBS. Following draining of the plates, 100 μL of 
lauryl sulfate solution (1%, Sodium Dodecyl 
Sulfate, Sigma, Germany) was added to each well 
and plates were shaken on an orbital plate shaker 
for 10 min at room temperature to release all of 
the dye from the cells. Samples were transferred to 
cuvettes and absorbency was recorded at 540 nM 
on a microtiter plate spectrophotometer 
(TitertekTwinreader, Finland).  
Inhibition of cell proliferation was 
determined and expressed as per cent of 
absorbance of NR extracted from control cells 
(defined as 100%). IC50 values were determined by 
linear regression method.3, 7-11 
 
Statistical analysis 
The results of in vitro study are given as 
Mean ± Standard Deviation obtained from three 
independent experiments. The results of in vivo 
study were expressed also as Mean ± Standard 
Deviation and analyzed with Student’s t-test for 
paired data using Origin 6.1 package software. All 
data were analyzed at a 95% confidence interval 
(α= 0.05). 
 
Results and Discussion 
The results of the bioactivity of 
Phyllanthus amarus extract on the selected model 
systems are summarized in Table 1. 
It is deduced from the table 1 that the 
Phyllanthus amarus displayed a good anti-malarial 
activity both in vitro and in vivo (i.e IC50 < 10 
µg/mL: P. amarus IC50 = 5.742±0.416 µg/mL and 
%I > 33.00±2.630: %I= 34.605±3.501). The 
ethanolic crude extract from this herbal medicine 
displayed also cytotoxic effect towards P-388 cells 
(IC50 < 10 µg/mL) with a therapeutic index of 
1.006. These results are consistent with previously 
reported data. Indeed, a recent investigation of the 
antiplasmodial activity of the extracts of 
Phyllanthus amarus from Nigeria on Plasmodium yoelii 
(a resistant malaria parasite strain used in animal 
studies) infection in mice revealed a dose-
dependent chemotherapeutic activity (with the 
chemo-suppression rate of 79% at 1600 
mg/kg/day).24 While using Brine shrimp lethality 
bioassay, it was reported that the whole plant of P. 
amarus from Bangladesh exhibited potent 
cytotoxicity with a LC50 value of 20.16 μg/mL.25  
The present study validated the 
antimalarial effectiveness of P. amarus from DRC. 
Published research works revealed that this herbal 
medicine have numerous phytocompounds such 
as alkaloids, flavonoids, tannins, lignins, 
polyphenolic compounds and tetracyclic 
triterpenoids. Among phyto-constituents isolated 
from this plant are Geraniin, corilagin, 1,6-
digalloylglucopyranoside rutin, quercetin-3-O-
glucopyranoside, Amarulone, Phyllanthusiin D & 
Amariin (tannins); Niranthin, Nirtetralin, 
Phyltetralin, Hypophyllanthin, Phyllanthin, 
demethylenedioxy-niranthin, 5- demethoxy-
niranthin, Isolintetralin (lignans); Isobubbialine 
and Epibubbialine (alkaloids), 2Z, 6Z, 10Z, 14E 
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Table 1. Anti-malarial and cytotoxic activities of Phyllanthus amarus   
Family 
Medicinal plant 
(Country of origin) 
Part Used in the 
present study 
IC50 (µg/mL) Therapeutic 
index 
% chemosuppression 
(P. yoelii) Pf FCM 29 P388 Cells 
Phyllanthaceae 
P. amarus Schumach. & Thonn. 
(Democratic Republic of the 
Congo) 
Whole plant 5.742±0.416 5.776±0,260 1.006 34.605±3.501 
 
 (Legend: Positive control: Chloroquine (IC50=265.480±45.130 nM); Cinchona sp ethanolic crude extract 100 mg/kg (%Chemosuppression of P. 




Thus justifying it large spectrum of 
pharmacological activities (including antiviral, 
antibacterial, antiplasmodial, anti-inflammatory, 
anti-malarial, antimicrobial, anticancer, 
antidiabetic, hypolipidemic, antioxidant, 
hepatoprotective, nephroprotective and diurectic 
properties) and it use in folk medicine.1,2 
Although, in the present study, we have 
demonstrated that P. amarus is cytotoxic against 
P388 cell lines with an IC50 value less than 10 
µg/mL. Hence, the wide use of this medicinal 
plant in Congolese Folk Medicine as anti-malarial 




The goal of this study was to validate 
scientifically the antimalarial effectiveness and 
safety of P. amarus. The results indicate that this 
herbal medicine has good in vitro and in vivo 
antiplasmodial activities. However the plant 
species displayed cytotoxic effects against P388 
cells. So, the wide use of this medicinal plant in 
Congolese Folk Medicine as antimalarial herbal 
could constitutes a great risk of population 
poisoning. From this study, it can be predicted 
that P. amarus possess secondary metabolites with 
interesting cytotoxic potency and could lead to the 
discovery of useful anti-cancer drugs of plant 
origin 
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